Crimea

Crimea is a autoflowering evenly balanced hybrid (50% indica/50% sativa) strain that has quietly built a dedicated following. This infamous bud boasts a THC level that ranges from 23-29% on average, with 0.9% CBD. It is sold as autoflower seeds, and it remains one of the most requested cuts in its class year after year.

Users describe the Crimea high as a true two-sided experience — an energizing cerebral lift arrives first, sliding gradually into a mellow body calm that relaxes without switching you off completely. Neither side ever overpowers the other, which is exactly why well-bred hybrids like this one earn permanent shelf space. These combined effects make Crimea a frequent pick among patients dealing with chronic stress, muscle tension and mild to moderate depression, and a reliable standby for anyone medicating on a schedule.

On the palate, expect lemon and berry up front, backed by an aroma that fills the room the moment the jar opens. The smoke is smooth on the inhale with a berry finish that builds the longer the session runs. This bud has long tapered spade-shaped olive green nugs with deep purple undertones, rust-colored hairs and a fine dusting of milky white trichomes.

For growers, Crimea offers an easy, forgiving grow that suits first-time cultivators — expect plants finishing in as little as 8-9 weeks from germination, at home indoors or outdoors. It shrugs off common beginner mistakes, and yields stay respectable even when conditions are less than perfect. Plants stretch to a medium height with strong side branching, equally at home in a tent or a garden bed. Its genetics run through the wider Crimea family — see Crimea Blue for close relatives worth comparing before you buy.